DE2814121C3 - Verfahren zur Herstellung eines bei der Krebs-Diagnose verwendbaren spezifischen Immunserums K K Saikin Kagaku Kenkyujo, Sendaishi - Google Patents

Verfahren zur Herstellung eines bei der Krebs-Diagnose verwendbaren spezifischen Immunserums K K Saikin Kagaku Kenkyujo, Sendaishi

Info

Publication number
DE2814121C3
DE2814121C3 DE2814121A DE2814121A DE2814121C3 DE 2814121 C3 DE2814121 C3 DE 2814121C3 DE 2814121 A DE2814121 A DE 2814121A DE 2814121 A DE2814121 A DE 2814121A DE 2814121 C3 DE2814121 C3 DE 2814121C3
Authority
DE
Germany
Prior art keywords
iap
serum
immune serum
cancer
specific immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2814121A
Other languages
German (de)
English (en)
Other versions
DE2814121A1 (de
DE2814121B2 (de
Inventor
Nakao Ishida
Fumio Kitame
Yoshiji Matsuda
Hiroaki Koganei Tokio Motoki
Miyagi Sendai
Keiji Tamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KK Kayaku Kosei Bushitsu Kenkyujo Tokio
KK Saikin Kagaku Kenkyujo Sendaishi Miyagi
Original Assignee
KK Kayaku Kosei Bushitsu Kenkyujo Tokio
KK Saikin Kagaku Kenkyujo Sendaishi Miyagi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KK Kayaku Kosei Bushitsu Kenkyujo Tokio, KK Saikin Kagaku Kenkyujo Sendaishi Miyagi filed Critical KK Kayaku Kosei Bushitsu Kenkyujo Tokio
Publication of DE2814121A1 publication Critical patent/DE2814121A1/de
Publication of DE2814121B2 publication Critical patent/DE2814121B2/de
Application granted granted Critical
Publication of DE2814121C3 publication Critical patent/DE2814121C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2814121A 1977-06-16 1978-04-01 Verfahren zur Herstellung eines bei der Krebs-Diagnose verwendbaren spezifischen Immunserums K K Saikin Kagaku Kenkyujo, Sendaishi Expired DE2814121C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7134977A JPS548714A (en) 1977-06-16 1977-06-16 Production of specific antiserum

Publications (3)

Publication Number Publication Date
DE2814121A1 DE2814121A1 (de) 1978-12-21
DE2814121B2 DE2814121B2 (de) 1979-10-04
DE2814121C3 true DE2814121C3 (de) 1980-06-26

Family

ID=13457921

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2814121A Expired DE2814121C3 (de) 1977-06-16 1978-04-01 Verfahren zur Herstellung eines bei der Krebs-Diagnose verwendbaren spezifischen Immunserums K K Saikin Kagaku Kenkyujo, Sendaishi

Country Status (7)

Country Link
US (1) US4269765A (enExample)
JP (1) JPS548714A (enExample)
CA (1) CA1093964A (enExample)
CH (1) CH640639A5 (enExample)
DE (1) DE2814121C3 (enExample)
FR (1) FR2394805A1 (enExample)
GB (1) GB1565333A (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56132563A (en) * 1980-03-21 1981-10-16 Terumo Corp Reagent for testing biological material and use thereof
JPS56142459A (en) * 1980-04-08 1981-11-06 Terumo Corp Living substance inspecting method and container therefore
US4447545A (en) * 1980-11-03 1984-05-08 New England Deaconess Hospital Bladder cancer detection
US4656025A (en) * 1985-04-19 1987-04-07 Emmanuel Deutsch Quantitative screening assay of tumor globulin from gastric juice
JPS62135297U (enExample) * 1986-02-20 1987-08-26
JPS62161494U (enExample) * 1986-04-01 1987-10-14
JPS6344592U (enExample) * 1986-09-08 1988-03-25

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819822A (en) * 1969-12-18 1974-06-25 Kowa Co Diagnostic agent for detection of primary hepatoma
SE388284B (sv) * 1969-12-18 1976-09-27 Kowa Co Gelmedium for diagnos av primert hepatom medelst immundiffusion eller elektrofores
GB1291134A (en) * 1970-01-21 1972-09-27 Anvar A process for the production of mammal cell anti-sera
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine
GB1388719A (en) * 1971-09-02 1975-03-26 Hadassah Medical Relief Ass In Pure t-globulin and its anti-serum
FR2222084B1 (enExample) * 1973-03-22 1976-05-14 Fontaine Michel
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm

Also Published As

Publication number Publication date
DE2814121A1 (de) 1978-12-21
GB1565333A (en) 1980-04-16
FR2394805A1 (fr) 1979-01-12
FR2394805B1 (enExample) 1980-08-08
DE2814121B2 (de) 1979-10-04
CH640639A5 (de) 1984-01-13
JPS548714A (en) 1979-01-23
US4269765A (en) 1981-05-26
JPS6118699B2 (enExample) 1986-05-14
CA1093964A (en) 1981-01-20

Similar Documents

Publication Publication Date Title
DE2029499C3 (de) Verfahren zum Nachweis der Anwesenheit von carcinoembryonalen Antigenen im Blut
CH627187A5 (enExample)
DE1598945A1 (de) Verfahren zur Bestimmung von Proteinen und Polypeptiden
DE2126680A1 (de) Carcinoembryonisches Antigen
DE2814121C3 (de) Verfahren zur Herstellung eines bei der Krebs-Diagnose verwendbaren spezifischen Immunserums K K Saikin Kagaku Kenkyujo, Sendaishi
DE3879085T2 (de) Snrnp-a-antigen und fragmente davon.
DE2900546B2 (de) Verfahren zum Standardisieren einer markierten Bindungskomponente, welche in einem spezifischen Bindungstest-Verfahren mit einem Liganden reagiert, gegen einen Liganden-Referenzstandard und Verwendung der standardisierten markierten Bindungskomponente in spezifischen Bindungstest-Verfahren
DE60035267T2 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
DE2714751C2 (enExample)
CH645727A5 (de) Praeparat zur bestimmung von menschlichem beta-2-mikroglobulin, verfahren zu seiner herstellung und seine verwendung.
DE3410694C2 (enExample)
DE2126128A1 (de) Medizinisches Testverfahren, Reagens und Additiv zur Durchführung des Verfahrens
DE3915344A1 (de) Serumdiagnose-verfahren
CH617853A5 (en) Process for the preparation of a tumour polypeptide antigen
DE2062558A1 (de) Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben
DE3005417A1 (de) Verfahren zur bestimmung von immunkomplexen
AT276625B (de) Diagnostikum zum quantitativen immunelektrophoretischen Nachweis von Gammaglobulinen und Verfahren zu dessen Herstellung
DE2749554A1 (de) Peptidkomplexe aus desoxyribonucleinsaeurehaltigen organismen mit jeweils spezifischen antigendeterminanten fuer den organismus, aus dem sie gewonnen werden, zur diagnostischen, prophylaktischen und therapeutischen anwendung
DE1617734C (de) Verfahren zur Herstellung eines immunologischen Reagens
DE2117473A1 (de) Serodiagnostisches Präparat
DE2551431A1 (de) Anti-embryoserum und schwangerschafts- bzw. traechtigkeits-diagnoseverfahren
DE2652684C3 (de) Wasserlösliches Protein (Antigen) aus β-hämolysierenden Streptokokken der Gruppe A
DE2347628C3 (de) Verfahren zur Gewinnung immunsuppressiver Gammaglobuline und Verwendung der Gammaglobuline zur Behandlung der Implanat-Abstoflung und von Autoaggressionskrankheiten
DE2815758A1 (de) Peptidkomplexe aus dns-haltigen organismen
CH615512A5 (en) Method for the determination of carcinoembryonic antigen

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee